PTPN22 620W allele is not associated with aplastic anemia

American Journal of Hematology

Volumn 82, Issue 4, 2007, Pages 291-292

  Graf, Solomon A ^a,b   Calado, Rodrigo T ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aplastic anemia; Autoimmune disease; Polymorphism; PTPN22

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLELE; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 34147129127     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20768     Document Type: Article

References (10)

1. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006; Jun 15, Epub ahead of print.
2. Saunthararajah Y, Nakamura R, Nam JM, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002;100:1570-1574.
3. Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006;12:90-98.
4. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005:76:561-571.
5. Jagiello P, Aries P, Arning L, et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005;52:4039-4043.
6. Feng X, Chuhjo T, Sugimori C, et al. Diazepam-binding inhibitor-related protein 1: A candidate autoantigen in acquired aplastic anemia patients harboring a minor populatoin of paroxysmal nocturnal hemoglobinuria-type cells. Blood 2004;104:2425-2431.
7. Hirano N. Butler MO, von Bergwelt-Baildon MS, et al. Autoantibodies frequently detected in patients with aplastic anemia. Blood 2003;102:4567-4575.
8. Quiquandon I, Morel P, Lai JL, et al. Primary Sjogren's syndrome and aplastic anemia. Ann Rheum Dis 1997;56:438.
9. Pavithran K, Raji NL, Thomas M. Aplastic anemia complicating systemic lupus erythematosus-Report of a case and review of the literature. Rheumatol Int 2002;22:253-255.
10. Svahn J, Capasso M, Lanciotti M. et al. The polymorphisms -318 C→T in the promoter and 49 A→G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population. Bone Marrow Transplant 2005;35:589-592.